Company Sirona Biochem Corp Toronto S.E.
Equities
SBM
CA82967M1005
Biotechnology & Medical Research
Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cosmetic and Pharmaceutical Active Ingredients
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -94.82% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Howard Verrico
CEO | Chief Executive Officer | - | 06-10-18 |
Director of Finance/CFO | - | 09-04-28 | |
Chief Tech/Sci/R&D Officer | - | 11-03-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Howard Verrico
CEO | Chief Executive Officer | - | 06-10-18 |
Alex Marazzi
BRD | Director/Board Member | - | 06-10-18 |
Director of Finance/CFO | - | 09-04-28 | |
Chief Tech/Sci/R&D Officer | - | 11-03-30 | |
Jason Tian
BRD | Director/Board Member | - | 19-06-06 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 256,824,505 | 229,289,516 ( 89.28 %) | 0 | 89.28 % |
Company contact information
Sirona Biochem Corp.
595 Burrard Street Suite 1600
V7X 1L4, Vancouver
+604-641-4466
http://www.sironabiochem.com![address Sirona Biochem Corp(SBM)](https://cdn.zonebourse.com/static/address/5273075.png)
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+28.86% | 52.73B | |
+36.95% | 39B | |
-9.47% | 38.52B | |
+25.41% | 30.38B | |
-11.17% | 26.39B | |
+10.53% | 26.08B | |
+43.89% | 14.15B | |
+33.95% | 12.6B | |
-6.17% | 11.51B |